Salarius Pharmaceuticals salariuspharma.com


Public list: Pharma Startups (4733) Cancer Therapeutics (1136)

Salarius Pharmaceuticals is an oncology company developing inhibitors of LSD1 (Lysine-Specific Demethylase). Salarius' lead compound, SP-2577, is moving into clinical development for the treatment of Ewing's Sarcoma and prostate cancer. SP-2577 has the potential for orphan status and fast-track approval.

Salarius Pharmaceuticals is an oncology company developing inhibitors of LSD1 (Lysine-Specific Demethylase). Salarius' lead compound, SP-2577, is moving into clinical development for the treatment of Ewing's Sarcoma and prostate cancer. SP-2577 has t...Show all

Company (Alive / Active)

Phone: 203-546-0376

Fax:

2450 Holcombe Blvd
Suite J-608
Houston, 77021
Texas, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Salarius Pharmaceuticals $1M Aug 1, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Salarius Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)